Public expenditure

Overview

Estimating drug-related public expenditure and developing the economic evaluation of drug policy have been on the European agenda for more than a decade. However, only a few countries have produced comprehensive estimates of drug-related public expenditure. Moreover, those who have done it have generally used non-comparable methodologies. The EMCDDA supports the development of national and supra-national estimates of drug-related public expenditure in Europe. 

Read more

Loading